Moderna MRNA
$ 43.22
1.09%
Quarterly report 2024-Q3
added 11-07-2024
Moderna Income Statement 2011-2024 | MRNA
Annual Income Statement Moderna
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
36.7 B | 54.8 B | 61.9 B | 59 B | 6.94 B | 4.97 B | - | - | - | - | - | - | - |
Shares |
382 M | 394 M | 403 M | 381 M | 331 M | 329 M | - | - | - | - | - | - | - |
Historical Prices |
96.2 | 139 | 154 | 155 | 25.9 | 22.6 | - | - | - | - | - | - | - |
Net Income |
-4.71 B | 8.36 B | 12.2 B | -747 M | -514 M | -385 M | -256 M | -216 M | - | - | - | - | - |
Revenue |
6.85 B | 19.3 B | 18.5 B | 803 M | 60.2 M | 135 M | 206 M | 108 M | - | - | - | - | - |
Cost of Revenue |
4.69 B | 5.42 B | 2.62 B | 8 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.24 B | 9.42 B | 13.3 B | -763 M | -546 M | -413 M | -269 M | -224 M | - | - | - | - | - |
Interest Expense |
-124 M | -45 M | -29 M | -6 M | -8 M | 1.84 M | -1.88 M | -2.71 M | - | - | - | - | - |
EBITDA |
-3.62 B | 9.77 B | 13.5 B | -732 M | -515 M | -388 M | -249 M | -209 M | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 606 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.55 B | 1.13 B | 567 M | 188 M | 110 M | 94.3 M | 64.7 M | 57.4 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Moderna
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
385 M | 384 M | 382 M | 382 M | 381 M | 381 M | 386 M | 385 M | 390 M | 396 M | 402 M | 403 M | 404 M | 402 M | 400 M | 399 M | 395 M | 381 M | 353 M | 337 M | 331 M | 329 M | 329 M | 329 M | 66.3 M | 65.9 M | 65.4 M | 65.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
13 M | -1.28 B | -1.18 B | - | -3.63 B | -1.38 B | 79 M | - | 1.04 B | 2.2 B | 3.66 B | - | 3.33 B | 2.78 B | 1.22 B | - | -233 M | -117 M | -124 M | - | -123 M | -135 M | -133 M | - | -80.3 M | -90.6 M | -72.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.86 B | 241 M | 167 M | - | 1.83 B | 344 M | 1.86 B | - | 3.36 B | 4.75 B | 6.07 B | - | 4.97 B | 4.35 B | 1.94 B | - | 157 M | 67 M | 8 M | 14.1 M | 17 M | 13.1 M | 16 M | 35.4 M | 41.8 M | 28.9 M | 29 M | 91.9 M | 42.5 M | 41.1 M | 30.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
514 M | 115 M | 96 M | - | 2.24 B | 731 M | 792 M | - | 1.1 B | 1.38 B | 1.02 B | - | 722 M | 750 M | 193 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-70 M | -1.36 B | -1.27 B | - | -2.01 B | -1.87 B | -366 M | - | 1.17 B | 2.45 B | 4.23 B | - | 3.56 B | 3.06 B | 1.27 B | - | -235 M | -122 M | -131 M | -131 M | -131 M | -144 M | -142 M | -153 M | -85.8 M | -97 M | -77.4 M | -41.8 M | -67.9 M | -94.2 M | -65.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-12 M | -27 M | -19 M | - | -51 M | 14 M | -48 M | - | -7 M | -13 M | -13 M | - | -10 M | -2 M | -10 M | - | -3 M | -2 M | -1 M | - | -1.88 M | -1.88 M | -1.93 M | - | -1.03 M | 171 K | -183 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-19 M | -1.32 B | -1.23 B | - | -1.77 B | -1.78 B | -288 M | - | 1.28 B | 2.52 B | 4.31 B | - | 3.63 B | 3.13 B | 1.28 B | - | -227 M | -114 M | -124 M | -131 M | -123 M | -136 M | -134 M | -153 M | -79.3 M | -91.1 M | -72.2 M | -41.8 M | -67.9 M | -94.2 M | -65.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 393 M | 188 M | 139 M | 145 M | 148 M | 157 M | 158 M | 188 M | 128 M | 126 M | 106 M | 134 M | 110 M | 135 M | 95.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
281 M | 268 M | 274 M | - | 442 M | 332 M | 305 M | - | 278 M | 211 M | 268 M | - | 168 M | 121 M | 77 M | - | 48 M | 37 M | 24 M | - | 28.2 M | 28.5 M | 27.3 M | - | 18.5 M | 21.4 M | 16.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency